miR-199a-3p plays an anti-tumorigenic role in lung adenocarcinoma by suppressing anterior gradient 2
暂无分享,去创建一个
[1] P. Chu,et al. Advances in Understanding Mitochondrial MicroRNAs (mitomiRs) on the Pathogenesis of Triple-Negative Breast Cancer (TNBC) , 2021, Oxidative medicine and cellular longevity.
[2] P. Show,et al. How Far Have We Explored Fungi to Fight Cancer? , 2021, Seminars in cancer biology.
[3] Ping Wang,et al. Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX) , 2021, Bioengineered.
[4] Liping Wang,et al. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1. , 2020, IUBMB life.
[5] Hua Lu,et al. miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation , 2020, Annals of translational medicine.
[6] Jung-Il Lee,et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma , 2020, Nature Communications.
[7] J. Bai,et al. Down-Regulation of ZEB1 by miR-199a-3p Overexpression Restrains Tumor Stem-Like Properties and Mitochondrial Function of Non-Small Cell Lung Cancer , 2020, OncoTargets and therapy.
[8] Donghwa Kim,et al. Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers , 2020, AntiCancer Research.
[9] Yiyan Lei,et al. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). , 2020, International immunopharmacology.
[10] J. Baik,et al. MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination , 2019, Molecular oncology.
[11] Mohammad Hossein Khosravi,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 , 2019, JAMA oncology.
[12] Y. Mou,et al. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis. , 2019, Pathology, research and practice.
[13] Xiaowei Wang,et al. miRDB: an online database for prediction of functional microRNA targets , 2019, Nucleic Acids Res..
[14] Sang-Mo Kwon,et al. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells. , 2019, Biochemical and biophysical research communications.
[15] Chang Liu,et al. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p , 2019, Molecular and Cellular Endocrinology.
[16] Fan Zhang,et al. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2 , 2019, Journal of experimental & clinical cancer research : CR.
[17] Wenjie Yang,et al. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis , 2019, Bioengineered.
[18] M. Gross,et al. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis , 2018, Oncogene.
[19] Yanyan Huang,et al. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker , 2018, BMB reports.
[20] Lei Hua,et al. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene , 2018, Cancer Cell International.
[21] Lan Yao,et al. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[22] F. Hirsch,et al. Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules. , 2018, Journal of thoracic disease.
[23] A. Hamburger,et al. MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4 , 2018, Oncotarget.
[24] S. Sabbioni,et al. miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model , 2018, Molecular therapy. Nucleic acids.
[25] L. Qin,et al. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8 , 2018, Oncology reports.
[26] Bo Zhu,et al. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. , 2017, Lung cancer.
[27] C. Stephan,et al. miR‐199a‐3p and miR‐214‐3p improve the overall survival prediction of muscle‐invasive bladder cancer patients after radical cystectomy , 2017, Cancer medicine.
[28] T. Yuan,et al. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1 , 2017, Oncotarget.
[29] T. Yuan,et al. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1 , 2017, Oncotarget.
[30] Thomas D. Schmittgen,et al. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2 , 2017, Cell Death and Disease.
[31] Jae Cheol Lee,et al. Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma , 2016, Tuberculosis and respiratory diseases.
[32] Edward J. Kim,et al. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis , 2016, Oncotarget.
[33] Yazeng Huang,et al. AGR2 is associated with gastric cancer progression and poor survival , 2016, Oncology letters.
[34] S. Horvath,et al. High expression of AGR2 in lung cancer is predictive of poor survival , 2015, BMC Cancer.
[35] Christina Backes,et al. Longitudinal study on circulating miRNAs in patients after lung cancer resection , 2015, Oncotarget.
[36] Z. Du,et al. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells , 2015, Cellular and Molecular Neurobiology.
[37] Zhenggang Zhu,et al. MiR‐199a‐3p promotes gastric cancer progression by targeting ZHX1 , 2014, FEBS letters.
[38] A. Park,et al. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells. , 2014, Oncology reports.
[39] Jiwei Huang,et al. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma , 2014, Tumor Biology.
[40] Xuelin Huang,et al. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. , 2013, Biostatistics, bioinformatics and biomathematics.
[41] H. Wanibuchi,et al. AGR2 as a potential biomarker of human lung adenocarcinoma. , 2012, Osaka city medical journal.
[42] Federico Rea,et al. Anterior Gradient 2 Overexpression in Lung Adenocarcinoma , 2012, Applied immunohistochemistry & molecular morphology : AIMM.
[43] Rongkuan Hu,et al. miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. , 2018, Cancer letters.
[44] H. Wanibuchi,et al. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma. , 2011, Cancer biomarkers : section A of Disease markers.